Laeeque Ahmed, Ahmed Basalim, N. Alwagdani, Bsaim Altirkistani, Ziyad M. Albassam, Mohammed A Almatrafi, Faisal S Alrubaei, Adnan Alzanbagi
{"title":"沙特阿拉伯某三级转诊中心ercp的特点、适应证和转归回顾性分析","authors":"Laeeque Ahmed, Ahmed Basalim, N. Alwagdani, Bsaim Altirkistani, Ziyad M. Albassam, Mohammed A Almatrafi, Faisal S Alrubaei, Adnan Alzanbagi","doi":"10.1136/gutjnl-2021-iddf.90","DOIUrl":null,"url":null,"abstract":"IDDF2021-ABS-0116 Figure 2 Abstract IDDF2021-ABS-0116 Figure 3 AbstractsIDDF2021-ABS-0116 Figure 3 Abstracts Gut 2021;70(Suppl 2):A1–A150 A85 on S etem er 5, 2021 by gest. P rocted by coright. http/gut.bm jcom / G t: frst pulished as 10.113utjnl-2021-ID D F 92 on 2 S etem er 221. D ow nladed fom 32 studies described tumors with a specified primary, with gastric cancer being the most common. (IDDF2021-ABS-0116 Figure 1) Pooled data showed that the 3and 5-year OS were 45% (95% CI 0.40-0.50) and 35% (95% CI 0.31-0.19), (IDDF2021-ABS-0116 Figure 2, IDDF2021-ABS-0116 Figure 3) respectively, whereas the 3and 5-year DFS were 33% (95% CI 0.29-20.37) and 27% (95% CI 0.23-0.32), respectively (IDDF2021-ABS-0116 Figure 4, IDDF2021-ABS-0116 Figure 5). The postoperative morbidity rate was 24% (95% CI 0.20-0.29), whereas the 30-day mortality was 2% (95% CI 0.01-0.03). Gastric cancer with liver metastasis had 3-year and 5-year OS of 39% (95% CI 0.32-0.46) and 25% (95% CI 0.20-0.31). Conclusions Hepatectomy for NCNNLM may achieve favourable survival outcomes, with low surgical morbidities and mortalities in selected patients. IDDF2021-ABS-0118 FACTORS ASSOCIATED WITH THE PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DETECTED IN JAPANESE ADULTS UNDERGOING HEALTH","PeriodicalId":9921,"journal":{"name":"Chinese Journal of Clinical Hepatology","volume":"66 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"IDDF2021-ABS-0102 Retrospective analysis of characteristics, indications and outcomes of ercp in a tertiary referral center of Saudi Arabia\",\"authors\":\"Laeeque Ahmed, Ahmed Basalim, N. Alwagdani, Bsaim Altirkistani, Ziyad M. Albassam, Mohammed A Almatrafi, Faisal S Alrubaei, Adnan Alzanbagi\",\"doi\":\"10.1136/gutjnl-2021-iddf.90\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IDDF2021-ABS-0116 Figure 2 Abstract IDDF2021-ABS-0116 Figure 3 AbstractsIDDF2021-ABS-0116 Figure 3 Abstracts Gut 2021;70(Suppl 2):A1–A150 A85 on S etem er 5, 2021 by gest. P rocted by coright. http/gut.bm jcom / G t: frst pulished as 10.113utjnl-2021-ID D F 92 on 2 S etem er 221. D ow nladed fom 32 studies described tumors with a specified primary, with gastric cancer being the most common. (IDDF2021-ABS-0116 Figure 1) Pooled data showed that the 3and 5-year OS were 45% (95% CI 0.40-0.50) and 35% (95% CI 0.31-0.19), (IDDF2021-ABS-0116 Figure 2, IDDF2021-ABS-0116 Figure 3) respectively, whereas the 3and 5-year DFS were 33% (95% CI 0.29-20.37) and 27% (95% CI 0.23-0.32), respectively (IDDF2021-ABS-0116 Figure 4, IDDF2021-ABS-0116 Figure 5). The postoperative morbidity rate was 24% (95% CI 0.20-0.29), whereas the 30-day mortality was 2% (95% CI 0.01-0.03). Gastric cancer with liver metastasis had 3-year and 5-year OS of 39% (95% CI 0.32-0.46) and 25% (95% CI 0.20-0.31). Conclusions Hepatectomy for NCNNLM may achieve favourable survival outcomes, with low surgical morbidities and mortalities in selected patients. IDDF2021-ABS-0118 FACTORS ASSOCIATED WITH THE PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DETECTED IN JAPANESE ADULTS UNDERGOING HEALTH\",\"PeriodicalId\":9921,\"journal\":{\"name\":\"Chinese Journal of Clinical Hepatology\",\"volume\":\"66 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Journal of Clinical Hepatology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/gutjnl-2021-iddf.90\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Clinical Hepatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/gutjnl-2021-iddf.90","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
IDDF2021-ABS-0116图2摘要IDDF2021-ABS-0116图3摘要siddf2021 - abs -0116 Gut 2021;70(补充2):A1-A150 A85在S etem er 5上,2021按最大。P由赖特保护。http /直觉。jj.com / gt:首次发表于10.113utjnl-2021-ID D F 92年2月1日,第221页。32项研究中有1项描述了具有特定原发灶的肿瘤,其中以胃癌最为常见。(IDDF2021-ABS-0116图1)汇总数据显示,3年和5年OS分别为45% (95% CI 0.40-0.50)和35% (95% CI 0.31-0.19) (IDDF2021-ABS-0116图2,IDDF2021-ABS-0116图3),而3年和5年DFS分别为33% (95% CI 0.29-20.37)和27% (95% CI 0.23-0.32) (IDDF2021-ABS-0116图4,IDDF2021-ABS-0116图5)。术后发病率为24% (95% CI 0.20-0.29), 30天死亡率为2% (95% CI 0.01-0.03)。胃癌合并肝转移的3年和5年OS分别为39% (95% CI 0.32-0.46)和25% (95% CI 0.20-0.31)。结论肝切除术治疗NCNNLM可能获得良好的生存结果,在选定的患者中手术发病率和死亡率较低。Iddf2021-abs-0118与日本健康成人非酒精性脂肪性肝病(nafld)存在相关的因素
IDDF2021-ABS-0102 Retrospective analysis of characteristics, indications and outcomes of ercp in a tertiary referral center of Saudi Arabia
IDDF2021-ABS-0116 Figure 2 Abstract IDDF2021-ABS-0116 Figure 3 AbstractsIDDF2021-ABS-0116 Figure 3 Abstracts Gut 2021;70(Suppl 2):A1–A150 A85 on S etem er 5, 2021 by gest. P rocted by coright. http/gut.bm jcom / G t: frst pulished as 10.113utjnl-2021-ID D F 92 on 2 S etem er 221. D ow nladed fom 32 studies described tumors with a specified primary, with gastric cancer being the most common. (IDDF2021-ABS-0116 Figure 1) Pooled data showed that the 3and 5-year OS were 45% (95% CI 0.40-0.50) and 35% (95% CI 0.31-0.19), (IDDF2021-ABS-0116 Figure 2, IDDF2021-ABS-0116 Figure 3) respectively, whereas the 3and 5-year DFS were 33% (95% CI 0.29-20.37) and 27% (95% CI 0.23-0.32), respectively (IDDF2021-ABS-0116 Figure 4, IDDF2021-ABS-0116 Figure 5). The postoperative morbidity rate was 24% (95% CI 0.20-0.29), whereas the 30-day mortality was 2% (95% CI 0.01-0.03). Gastric cancer with liver metastasis had 3-year and 5-year OS of 39% (95% CI 0.32-0.46) and 25% (95% CI 0.20-0.31). Conclusions Hepatectomy for NCNNLM may achieve favourable survival outcomes, with low surgical morbidities and mortalities in selected patients. IDDF2021-ABS-0118 FACTORS ASSOCIATED WITH THE PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DETECTED IN JAPANESE ADULTS UNDERGOING HEALTH